Infectious Disease
RSSArticles
-
Anticoagulation Plus Antiplatelet Therapy in Chronic Atherosclerosis
An analysis of the COMPASS trial for the secondary endpoint of mortality showed the combination of low-dose rivaroxaban and aspirin significantly lowered the all-cause mortality rate vs. low-dose aspirin alone.
-
No Harm in a Morning Cup of Joe
Habitual coffee consumption was inversely associated with a lower risk of cardiac arrythmia.
-
Statins, Cognitive Decline, and Dementia
An analysis of the ASPREE database showed that with almost five years of follow-up, statins are not associated with cognitive decline or dementia in a large group of elderly subjects in whom multiple tests of cognition were performed serially.
-
COVID-19 Vaccination: The Heart of the Matter
The occurrence of myocarditis after receipt of COVID-19 vaccines is most frequent in young men and generally benign, with rapid resolution only through supportive care. Careful analysis indicates the benefit of vaccination outweighs the risk in all groups for whom the vaccine is recommended.
-
Jury Still Out on Convalescent Plasma
One year after the FDA issued an emergency use authorization, investigators are struggling to draw firm conclusions about the efficacy of this solution against COVID-19.
-
FDA Gives Full Approval to Pfizer’s COVID-19 Vaccine
A significant milestone in the ongoing battle against the pandemic.
-
Infectious Disease Alert Updates
California mandates COVID-19 vaccine for healthcare workers; Seasonal coronavirus in stem cell transplant
-
Adherence to the Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Does Not Lead to Improved Clinical Outcomes
A longitudinal study from a single healthcare system found that adherence to the Medicare Severe Sepsis and Septic Shock Early Management Bundle resulted in some changes in process measures, but did not lead to improvements in clinical outcomes.
-
Treatment of Presumed Urinary Tract Infection in Afebrile Males: How Long Is Long Enough?
Symptom resolution after seven days of antibiotic therapy in afebrile males with presumed urinary tract infection was not inferior to 14 days of therapy.
-
COVID-19: Effective Post-Exposure Prophylaxis
Subcutaneous administration of a combination of anti-SARS-COV-2 antibodies effectively prevented COVID-19 in most household contacts of cases.